36 results on '"Angles-Cano, E."'
Search Results
2. Towards SI-traceability of lipoprotein (a) measurements: Comparison of a candidate LC-MRM-MS RMP method with commercially available immunoassays for evaluating commutability of candidate reference materials
3. Towards an SI-traceable reference measurement system for serum apolipoproteins (A), A-I, B, C-I, C-II, C-III and E
4. M265 Towards SI-traceability of lipoprotein (A) measurements: Comparison of a candidate LC-MRM-MS RMP method with commercially available immunoassays for evaluating commutability of candidate reference materials
5. M264 Towards an SI-traceable LC-MRM-MS based candidate reference measurement procedure for multiplex measurement of serum apolipoproteins (A), A-I, B, C-I, C-II, C-III and E
6. In transition to the next generation reference materials and reference measurement procedures for apolipoprotein standardization
7. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels
8. Les patients atteints de fibrose pulmonaire idiopathiques présentent une augmentation des acteurs de la fibrinolyse circulants
9. Membrane microvesicles: a circulating source for fibrinolysis, new antithrombotic messengers
10. Leukocyte- and endothelial-derived microparticles: a circulating source for fibrinolysis
11. Identification des microparticules dans les anévrismes intracrâniens
12. Matrix Metalloproteinase-10 Effectively Reduces Infarct Size in Experimental Stroke by Enhancing Fibrinolysis via a Thrombin-Activatable Fibrinolysis Inhibitor–Mediated Mechanism
13. E014 Generation de plasmine par les microparticules endotheliales : un nouveau mecanisme dans la regulation des activites proteolytiques de l’endothelium
14. ID: 129 The tissue-type plasminogen activator/plasminogen system induces alterations in cortical neuron organization and survival
15. P167 - Influence du nombre de kringles IV de l’apolipoprotéine (a) sur la modulation de l’interaction monocytes/collagène de type I
16. VASCULAR SMOOTH MUSCLE CELL APOPTOSIS IN ATHEROSCLEROTIC PLAQUES IS MEDIATED BY PLASMINOGEN ACTIVATION
17. Primary pulmonary hypertension, tissue plasminogen activator antibodies, and HLA-DQ7.
18. The antifibrinolytic effect of lipoprotein(a) in heterozygous subjects is modulated by the relative concentration of each of the apolipoprotein(a) isoforms and their affinity for fibrin
19. Autoanticorps antiactivateur tissulaire du plasminogène et thromboses artérielles et veineuses
20. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
21. Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?
22. Exploration du système fibrinolytique chez 16 patients atteints de maladie de buerger après épreuve de stimulation au DDAVP
23. Development of an internal standard for plasminogen activator inhibitor-1 PAI-1 and its use in a simplified assay for measuring pai-1 activity in human plasma
24. Identification and Cellular Localization of Plasminogen Activators from Human Glomeruli
25. The vascular plasminogen activator activity present in human plasma after venous occlusion circulates as a vPA-inhibitor complex
26. Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndrome
27. Thrombophlebitis in systemic lupus erythematosus
28. Production of monoclonal antibodies to the high fibrin-affinity, tissue- type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization
29. Thrombophlebitis in Systemic Lupus Erythematosus
30. Enhanced plasminogen-activator production by leukocytes in the human and murine Chediak-Higashi syndrome
31. Release of VIII R:Ag and VIII R:WF during thrombin and collagen induced aggregation
32. Endothelial Damage and Hypofibrinolysis in Systemic Lupus Erythematosus
33. Solid-phase fibrin-tissue-plasminogen-activator activity assay (sofia-TPA): TPA but not uk is specifically detected
34. Production of monoclonal antibodies to the high fibrin-affinity, tissue- type plasminogen activator of human plasma. Demonstration of its endothelial origin by immunolocalization
35. FIBRIN-BINDING STUDIES OF PRO-UROKINASE (PRO-UK) USING SOLID PHASE FIBRIN PLATES
36. Kinetic analysis of the interaction between plasminogen activator inhibitor-1 and tissue-type plasminogen activator
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.